Found: 129
Select item for more details and to access through your institution.
Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
- Published in:
- Journal of Surgical Oncology, 2009, v. 99, n. 7, p. 433, doi. 10.1002/jso.21277
- By:
- Publication type:
- Article
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1080729
- By:
- Publication type:
- Article
Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status.
- Published in:
- Journal of Palliative Medicine, 2023, v. 26, n. 4, p. 548, doi. 10.1089/jpm.2022.0495
- By:
- Publication type:
- Article
Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1409, doi. 10.3390/cancers16071409
- By:
- Publication type:
- Article
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 331, doi. 10.3390/cancers14020331
- By:
- Publication type:
- Article
Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5441, doi. 10.3390/cancers13215441
- By:
- Publication type:
- Article
Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1065, doi. 10.3390/cancers13051065
- By:
- Publication type:
- Article
Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1636, doi. 10.3390/cancers11111636
- By:
- Publication type:
- Article
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00538-x
- By:
- Publication type:
- Article
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-18
- By:
- Publication type:
- Article
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. e1066, doi. 10.1002/onco.13772
- By:
- Publication type:
- Article
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 593, doi. 10.1634/theoncologist.2019-0003
- By:
- Publication type:
- Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
- By:
- Publication type:
- Article
Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy.
- Published in:
- Oncology Letters, 2024, v. 27, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14243
- By:
- Publication type:
- Article
Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensive‑disease small cell lung cancer.
- Published in:
- Oncology Letters, 2023, v. 25, n. 3, p. N.PAG, doi. 10.3892/ol.2023.13696
- By:
- Publication type:
- Article
Decreasing expression of glucose-regulated protein GRP78/BiP as a significant prognostic predictor in patients with advanced laryngeal squamous cell carcinoma.
- Published in:
- Head & Neck, 2016, v. 38, n. 10, p. 1539, doi. 10.1002/hed.24471
- By:
- Publication type:
- Article
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 142, doi. 10.1159/000524077
- By:
- Publication type:
- Article
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 65, doi. 10.1159/000514841
- By:
- Publication type:
- Article
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2020, v. 65, n. 1-2, p. 21, doi. 10.1159/000508715
- By:
- Publication type:
- Article
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 3, p. 181, doi. 10.1159/000490949
- By:
- Publication type:
- Article
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 4, p. 205, doi. 10.1159/000456534
- By:
- Publication type:
- Article
The relationship between connective tissue and its microvasculature in the healthy dog gingiva.
- Published in:
- Journal of Periodontal Research, 1989, v. 24, n. 1, p. 45, doi. 10.1111/j.1600-0765.1989.tb00856.x
- By:
- Publication type:
- Article
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 3, p. 492, doi. 10.3390/medicina59030492
- By:
- Publication type:
- Article
Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 11, p. 1, doi. 10.3390/medicina57111273
- By:
- Publication type:
- Article
Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 11, p. 1, doi. 10.3390/medicina57111233
- By:
- Publication type:
- Article
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 9, p. 1, doi. 10.3390/medicina57090929
- By:
- Publication type:
- Article
Effects of Sex and Seasonal Climatic Changes on the Risk of Incidence of Anti-EGFR Therapy-Induced Rash in Cancer Patients: A Retrospective Study.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 8, p. 1, doi. 10.3390/medicina57080801
- By:
- Publication type:
- Article
Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Membranous Nephropathy as a Paraneoplastic Syndrome in Cancer of Unknown Primary.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1503, doi. 10.21873/invivo.13598
- By:
- Publication type:
- Article
Progression to Lymph Node Metastasis After Spontaneous Regression of Pulmonary Adenocarcinoma Following Biopsy.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1498, doi. 10.21873/invivo.13597
- By:
- Publication type:
- Article
Clinicopathological impact of VEGFR2 and VEGF‐C in patients with EGFR‐major mutant NSCLC receiving osimertinib.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 29, p. 2950, doi. 10.1111/1759-7714.15082
- By:
- Publication type:
- Article
Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2567, doi. 10.1111/1759-7714.15036
- By:
- Publication type:
- Article
Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2776, doi. 10.1111/1759-7714.14621
- By:
- Publication type:
- Article
A retrospective study of the efficacy and safety of naldemedine for opioid‐induced constipation in thoracic cancer patients.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 16, p. 2301, doi. 10.1111/1759-7714.14557
- By:
- Publication type:
- Article
Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1479, doi. 10.1111/1759-7714.14417
- By:
- Publication type:
- Article
Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 20, p. 2740, doi. 10.1111/1759-7714.14119
- By:
- Publication type:
- Article
Clinical impact of post‐progression survival on overall survival in patients receiving nivolumab monotherapy as a second‐line treatment for advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 8, p. 1171, doi. 10.1111/1759-7714.13886
- By:
- Publication type:
- Article
Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 864, doi. 10.1111/1759-7714.13864
- By:
- Publication type:
- Article
Pre‐existing interstitial lung disease does not affect prognosis in non‐small cell lung cancer patients with PD‐L1 expression ≥50% on first‐line pembrolizumab.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 3, p. 304, doi. 10.1111/1759-7714.13725
- By:
- Publication type:
- Article
Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3521, doi. 10.1111/1759-7714.13695
- By:
- Publication type:
- Article
Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 2867, doi. 10.1111/1759-7714.13622
- By:
- Publication type:
- Article
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 8, p. 2188, doi. 10.1111/1759-7714.13526
- By:
- Publication type:
- Article
Post‐progression survival is highly linked to overall survival in patients with non‐small‐cell lung cancer harboring sensitive EGFR mutations treated with first‐line epidermal growth factor receptor‐tyrosine kinase inhibitors
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 12, p. 2200, doi. 10.1111/1759-7714.13193
- By:
- Publication type:
- Article
Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1699, doi. 10.1111/1759-7714.12884
- By:
- Publication type:
- Article
Clinical significance of post-progression survival in lung cancer.
- Published in:
- Thoracic Cancer, 2017, v. 8, n. 5, p. 379, doi. 10.1111/1759-7714.12463
- By:
- Publication type:
- Article
Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer.
- Published in:
- Thoracic Cancer, 2016, v. 7, n. 6, p. 655, doi. 10.1111/1759-7714.12381
- By:
- Publication type:
- Article